Most people don’t know they have hypertension, and a new recommendation advises that pregnant women should be screened for blood pressure disorders at every appointment; patients in primary care face long wait times, which may be due to physician incentives under value-based payments; a lawsuit in New Jersey targets the residency requirement to allow aid in dying for those out of state.
Pregnant women should be screened for hypertensive disorders at each prenatal appointment, new guidelines suggest, as medical experts encourage action against growing threats to maternal health, according to The Wall Street Journal. This recommendation was made Tuesday by the US Preventive Services Task Force and broadens the 2017 guidance that said to regularly screen only for preeclampsia. Additionally, an estimated 1 in 3 adults globally live with hypertension, but most don’t receive adequate treatment because they don’t know they have it, according to a World Health Organization statement, reported The Washington Post. According to the statement, if just 50% of those with high blood pressure had control over the condition, 76 million deaths would be avoided by 2050.
In an opinion piece published by STAT News, an internist and clinical assistant professor highlighted that trouble in scheduling an urgent or time-sensitive appointment is now the most common complaint of patients in a primary care practice. This is not the exception, but the rule, the piece noted, and a 2022 countrywide survey showed that it takes an average of 20.6 days to get a family medicine appointment. The understaffed clinician workforce is just 1 reason for this trend, the author wrote; additionally, value-based payment has changed physician incentives in primary care practices other than concierge medicine.
Since 2019, aid in dying has been legal in New Jersey, but laws restrict assisting terminally ill residents to only those from the state, prompting a patient to take New Jersey officials to federal court to file a lawsuit to expand services, according to The New York Times. The lawsuit was filed in August and argues that New Jersey’s residency requirement violates the Constitutional privileges and immunities and equal protection clauses. The suit also says that prohibiting New Jersey doctors to assist in aid-in-dying care to out-of-state patients limits interstate commerce, the province of Congress. The New Jersey Attorney General’s office declined the opportunity to comment to the Times.
Humana Report Shows Benefits of Value-Based Care for Patients, Physicians
December 6th 2023Patients seen at value-based care clinics received more preventive screenings and had lower risks of hospitalization and emergency room visits, according to Humana’s 10th annual value-based care report.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
RHC Still Recommended Over Echocardiography for Detecting COPD-PH
November 20th 2023In a single-center, retrospective analysis, echocardiography demonstrated low sensitivity but high specificity for diagnosing pulmonary hypertension (PH) in advanced chronic obstructive pulmonary disease (COPD).
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen